Autosomal Dominant Polycystic Kidney Disease
A genetic disease where hundreds of large cysts grow inside the kidneys, destroying their ability to filter blood and causing massively enlarged kidneys, high blood pressure, and kidney failure.
Emergency Management: Subarachnoid Hemorrhage. Requires immediate stabilization, aggressive blood pressure lowering (labetalol or nicardipine IV), and emergent neurosurgical coiling or clipping.
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inherited kidney disorder, characterized by the progressive development and relentless expansion of numerous fluid-filled cysts in both kidneys. This massive cyst growth destroys normal renal parenchyma, leading to massive renomegaly and ultimately End-Stage Renal Disease (ESRD).
Detailed Overview
ADPKD is a systemic ciliopathy. Mutations in the PKD1 or PKD2 genes disrupt the function of polycystin-1 and polycystin-2, proteins located on the primary cilia of renal tubular epithelial cells. This defect causes abnormal intracellular calcium signaling and elevated cAMP, driving tubular cell proliferation and massive fluid secretion. Kidneys can eventually weigh over 5 kilograms each. Extra-renal manifestations are common and critical to survival, particularly the development of intracranial berry aneurysms and hepatic cysts.
Epidemiology & Demographics
Affects 1 in 400 to 1 in 1000 live births. Accounts for roughly 5-10% of all End-Stage Renal Disease cases worldwide. Occurs equally in men and women of all ethnicities.
Etiological Mechanism
Autosomal dominant inheritance. About 85% of cases are caused by mutations in the PKD1 gene (chromosome 16), which presents earlier and is more severe. 15% are caused by PKD2 mutations (chromosome 4), which presents later.
Primary Causes
Inherited genetic defect in polycystin proteins. Following a 'two-hit' somatic mutation model in individual tubular cells, cells lose differentiation, multiply, and secrete massive amounts of fluid, ballooning into cysts that detach from the nephron.
Defective polycystins on the primary cilia fail to sense mechanical flow, leading to a drop in intracellular Ca2+. This triggers adenylyl cyclase, raising intracellular cAMP. High cAMP activates PKA and the MAPK pathway, stimulating abnormal cell proliferation (cyst lining expansion) and upregulating CFTR channels (pumping chloride and water into the cyst). As cysts expand, they compress surrounding normal nephrons, causing localized ischemia. The kidneys respond by massive renin release, causing severe systemic hypertension, which further damages the surviving glomeruli.
Diagnostic Criteria & Guidelines
Pei-Ravine Ultrasound Criteria based on age and family history. For individuals with a family history: At age 15-39, the presence of ≥3 unilateral or bilateral renal cysts is diagnostic. At age 40-59, ≥2 cysts in each kidney is required. Genetic testing is reserved for ambiguous cases or living-related donor screening.
Strict blood pressure control to < 110/75 mmHg. ACE inhibitors (e.g., Lisinopril 10-40 mg PO daily) or ARBs are first-line to inhibit the dysregulated Renin-Angiotensin-Aldosterone System (RAAS) and preserve renal blood flow. Massive hydration (>3 Liters/day) to suppress endogenous vasopressin secretion.
Second-Line & Adjunctive Therapy
Tolvaptan (a Vasopressin V2 receptor antagonist) for patients with rapid disease progression (rapidly increasing TKV or dropping GFR). Dose titrated from 45/15 mg to 90/30 mg daily. It dramatically reduces cAMP in cysts, slowing growth by 50%. It causes profound polyuria (up to 7L/day) and requires strict monthly monitoring for severe hepatotoxicity.
Surgical & Procedural Management
Renal replacement therapy (Dialysis or Kidney Transplantation) for ESRD. Native nephrectomy is strictly avoided unless the native kidneys are causing intractable pain, recurrent infected cysts, or are so massive there is no physical room for the transplant graft.
Patient Counseling & Advice
Offer genetic counseling. Emphasize that hypertension is the silent driver of kidney destruction; they must take their ACE inhibitors even if they feel fine.
Follow-Up & Monitoring Schedule
Annual MRIs to calculate height-adjusted Total Kidney Volume (htTKV) using the Mayo classification system. Biannual GFR and electrolyte checks.
Preventive Strategies
No primary prevention exists. Preimplantation genetic diagnosis (PGD) with IVF is an option for affected parents wishing to ensure their offspring are unaffected.
ESRD is virtually inevitable, occurring at an average age of 54 for PKD1 and 74 for PKD2. Post-transplant prognosis is excellent, as the cysts do not recur in the grafted normal kidney.